Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01608672 · ClinicalTrials.gov registry record
Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 207
- Enrollment target
NCT01608672: Completed study, sponsored by Allergan.
NCT01608672 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 207 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01608672 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 207 participants
- Enrollment target
Study Summary
This is an observational study assessing patient satisfaction following at least 5 years of BOTOX® treatment for glabellar lines.
Primary Outcome
Participants assessed their overall satisfaction with their glabellar lines by answering FLSQ Question 5: "How satisfied are you with the effect your treatment had on your facial lines?" using a 5-point scale where: -2=very dissatisfied, -1=mostly dissatisfied, 0=neither dissatisfied nor satisfied, 1=mostly satisfied and 2=very satisfied. The percentage of participants mostly or very satisfied is reported.
Interventions
- BIOLOGICAL botulinum toxin Type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2012-04-01 |
| Est. Completion | 2012-12-31 |
What the finished NCT01608672 record still lists
NCT01608672 is an observational study that tracks outcomes without assigning an intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which botulinum toxin Type A is the first listed.
NCT01608672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01608672 about?
NCT01608672 is a clinical study titled "Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®". This is an observational study assessing patient satisfaction following at least 5 years of BOTOX® treatment for glabellar lines.
What is the current status of trial NCT01608672?
This trial is currently completed. The enrollment target is 207 participants. The study started on 2012-04-01. Estimated completion is 2012-12-31.
What interventions are being tested in trial NCT01608672?
The interventions under investigation include: botulinum toxin Type A (BIOLOGICAL).
Who is sponsoring clinical trial NCT01608672?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI